Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TACC3 |
| Upstream (Parents) |
|---|
| (<<) CEP55 → TACC3 |
| (<<) NCAPG → TACC3 |
| (<<) EZH2 → TACC3 |
| (<<) KIF14 → TACC3 |
| (<<) FAM57A → TACC3 |
| (<<) KIF18B → TACC3 |
| Downstream (Children) |
|---|
| TACC3 → PLA2G4B///JMJD7///JMJD7-PLA2G4B (>>) |
| TACC3 → TRAF4 (>>) |
| TACC3 → VEZT (>>) |
| TACC3 → RFX3 (>>) |
| TACC3 → PLXNA1 (>>) |
| TACC3 → AGRN (>>) |
| TACC3 → MICALL1 (>>) |
| TACC3 → B3GNTL1 (>>) |
| TACC3 → TECPR2 (>>) |
| TACC3 → NRGN (>>) |
| TACC3 → C15orf5 (>>) |
| TACC3 → BRWD1 (>>) |
